Offer - Urjas Oil for just ₹ 1 X
Erlonat 100 Tablet is a prescription medicine that is available as a Tablet. Pancreatic Cancer, Non-Small Cell Lung Cancer are some of its major therapeutic uses.
The right dosage of Erlonat 100 Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Erlonat 100 Tablet can also lead to other problems, which have been listed below. Such side effects of Erlonat 100 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Erlonat 100 Tablet's effect during pregnancy is Moderate and Moderate while nursing. In addition, Erlonat 100 Tablet's effects on the liver, heart and kidney are discussed below in the Erlonat 100 Tablet related warnings section.
Erlonat 100 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Erlonat 100 Tablet in conditions like Liver Disease, Kidney Disease, Lung Disease. Other conditions have been mentioned below in the Erlonat 100 Tablet contraindications section.
Drug interactions for Erlonat 100 Tablet have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Erlonat 100 Tablet is not safe while driving, and is not addiction.
Erlonat 100 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Erlonat 100 Tablet safe for pregnant women?
Erlonat may have some side effects during pregnancy. Pregnant women should discontinue the use of Erlonat, and talk to their doctor, if they notice any discomfort.
Is the use of Erlonat 100 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Erlonat. If you see any side effects, stop taking Erlonat immediately and talk to your doctor. Take Erlonat again, only after your doctor's advice.
What is the effect of Erlonat 100 Tablet on the Kidneys?
Erlonat does not damage the kidneys.
What is the effect of Erlonat 100 Tablet on the Liver?
Erlonat can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Erlonat 100 Tablet on the Heart?
You can take Erlonat without any fear of damage to the heart.
Erlonat 100 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Erlonat 100 Tablet unless your doctor advises you to do so -
Is this Erlonat 100 Tablet habit forming or addictive?
Erlonat 100 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Erlonat 100 Tablet. So it is best to avoid driving.
Is it safe?
Erlonat 100 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Erlonat 100 Tablet for mental disorders.
Interaction between Food and Erlonat 100 Tablet
Some foods when eaten with Erlonat 100 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erlonat 100 Tablet
It is difficult to say anything about the effect of Erlonat 100 Tablet and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516